Literature DB >> 30636596

Clinical Characteristics and Antibiotic Resistance of Mycoplasma Pneumoniae Pneumonia in Hospitalized Chinese Children.

Chen Yuan1, Fang-Mei Min1, Yin-Jie Ling1, Gang Li1, Hong-Zhou Ye1, Jia-Hui Pan1, Ling Wang1, Yan-Ping Xie2.   

Abstract

AIM: To analyze the clinical characteristics and antibiotic resistance of Mycoplasma pneumoniae pneumonia (MP) in Chinese patients, providing valuable information for the management of patients with MP.
METHODS: A total of 120 children who were hospitalized in The First Hospital of Huzhou between January and December 2016 for respiratory tract infection due to M. pneumoniae were enrolled in this study. Infection with M. pneumoniae was confirmed by ELISA for M. pneumoniae antibody, PCR, and throat culture. Antibiotic resistance was measured from the minimum inhibitory concentrations (MICs) of antibiotics. The 23S rRNA gene of M. pneumoniae was also examined for mutations using DNA sequencing. Patients with MP were classified into antibiotic resistance (n = 98) and no resistance (n = 20) groups. For the 98 patients showing antibiotic resistance, they were further stratified into subgroups based on the antibiotics initially prescribed: azithromycin or erythromycin (n = 78) and cephalosporin or penicillin (n = 20). Clinical characteristics were compared between the patient groups.
RESULTS: Antibiotic resistance group presented significantly longer febrile days compared to the no resistance group (P = 0.007). The number of febrile days after macrolide treatment was also longer in antibiotic resistance group than in no resistance group (P = 0.042). MP patients initially treated with azithromycin or erythromycin showed a longer average duration of respiratory symptoms (P = 0.046) and had a fever for more days after macrolide treatment (P = 0.009) compared to those received cephalosporin or penicillin. The average white blood cell count of patients treated with azithromycin or erythromycin was nearly half of those treated with cephalosporin or penicillin (P < 0.001). Nearly 90% of the resistant M. pneumoniae strains showed A to G substitution at position 2063 of the 23S rRNA gene.
CONCLUSION: The clinical characteristics and antibiotic resistance of MP were analyzed in 120 Chinese patients. DNA sequencing revealed a highly prevalent A2063G mutation in the 23S rRNA gene. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Mycoplasma pneumoniae; antibiotic resistance; macrolide; macrolide-resistant; pathogens; pneumonia.

Mesh:

Substances:

Year:  2018        PMID: 30636596     DOI: 10.2174/1386207322666190111112946

Source DB:  PubMed          Journal:  Comb Chem High Throughput Screen        ISSN: 1386-2073            Impact factor:   1.339


  3 in total

1.  Macrolide-Resistant Mycoplasma pneumoniae Infections in Pediatric Community-Acquired Pneumonia.

Authors:  Yu-Chin Chen; Wei-Yun Hsu; Tu-Hsuan Chang
Journal:  Emerg Infect Dis       Date:  2020-07       Impact factor: 6.883

2.  Vaccination with Mycoplasma pneumoniae membrane lipoproteins induces IL-17A driven neutrophilia that mediates Vaccine-Enhanced Disease.

Authors:  Arlind B Mara; Tyler D Gavitt; Edan R Tulman; Jeremy M Miller; Wu He; Emily M Reinhardt; R Grace Ozyck; Meagan L Goodridge; Lawrence K Silbart; Steven M Szczepanek; Steven J Geary
Journal:  NPJ Vaccines       Date:  2022-07-29       Impact factor: 9.399

3.  [Detection of drug-resistance genes of Mycoplasma pneumoniae in bronchoalveolar lavage fluid of children with refractory Mycoplasma pneumoniae pneumonia].

Authors:  Dan Chen; Na-Li Zhang; Ting Zhang; Xiao-Min Sun
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2021-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.